Brief: Hutchmed China Announces Partner Takeda's Japan Approval For Fruzaqla

HUTCHMED (China)

24/09/2024 08:09

Sept 24 (Reuters) - HUTCHMED (China) Ltd  0013.HK :
    * JAPAN APPROVAL FOR FRUZAQLA
    * APPROVAL BASED ON PHASE III FRESCO-2 TRIAL RESULTS

Source text for Eikon:  ID:nRSX3979Fa 
Further company coverage:  0013.HK 

 ((Reuters.Briefs@thomsonreuters.com;))